Risk of PE, Stroke, or Myocardial Infarction in Chronic Lower Extremity Venous Thrombosis
The risk of pulmonary embolism from chronic thrombosis of the left common femoral and profunda femoris veins with chronic partially occlusive thrombophlebitis at the saphenofemoral junction is low but not negligible, estimated at approximately 7-33% for PE depending on the extent of saphenous involvement, while the risk of stroke or myocardial infarction from this venous pathology is essentially zero.
Pulmonary Embolism Risk Assessment
Risk from Chronic Deep Vein Thrombosis
Chronic (organized) thrombus in the common femoral and profunda femoris veins poses minimal embolic risk because the thrombus has already undergone organization and endothelialization over time, making embolization highly unlikely. 1
The primary concern for PE arises during the acute phase of DVT (first 3-6 months), not from chronic, stable thrombosis. 2, 1
Patients with chronic DVT who have completed anticoagulation therapy and have no new acute thrombotic events have an annual recurrence risk of approximately 5.6 per 100 patient-years if the original event was provoked, which translates to roughly 2.5% annual risk of PE recurrence. 2
Risk from Saphenofemoral Junction Thrombophlebitis
Superficial thrombophlebitis at the saphenofemoral junction carries a surprisingly high PE risk of 7.5-33%, even when the thrombus appears isolated to the superficial system. 3, 4, 5
This risk exists regardless of whether the thrombus extends to the saphenofemoral junction itself—the mere presence of proximal greater saphenous vein thrombosis confers elevated PE risk. 3
In one study, 33% of patients with above-knee greater saphenous vein thrombophlebitis had high-probability perfusion lung scan findings consistent with PE, though most were asymptomatic. 3
A more recent study found 7.5% progression to DVT/PE in patients with isolated proximal greater saphenous vein thrombosis, with PE occurring exclusively in patients with thrombus within 5 cm of the saphenofemoral junction. 5
Risk from Profunda Femoris Vein Thrombosis
Isolated profunda femoris vein thrombosis can cause clinically significant pulmonary embolism, though this is less commonly recognized because the vessel is not well-visualized on traditional venography. 6
The profunda femoris vein communicates with the deep venous system and can serve as an embolic source. 6
Stroke and Myocardial Infarction Risk
There is no direct causal pathway between lower extremity venous thrombosis and either stroke or myocardial infarction in the absence of a right-to-left cardiac shunt (such as patent foramen ovale). 7
Venous thrombi do not embolize to the arterial circulation under normal cardiovascular anatomy. 7
Any association between venous thrombosis and arterial events (stroke, MI) would be indirect, mediated through shared risk factors such as malignancy, inflammatory states, or hypercoagulability, rather than through direct embolization. 7, 8
Clinical Context and Management Implications
If This Represents Chronic, Stable Disease
If the patient has already completed appropriate anticoagulation for the acute DVT episode and the current findings represent chronic, organized thrombus, the immediate embolic risk is very low. 1
The decision for extended anticoagulation depends on whether the original DVT was provoked or unprovoked, not on the presence of chronic residual thrombus. 2, 1
If There Is Acute-on-Chronic Thrombosis
If there is any acute component to the thrombosis (new symptoms, extension of thrombus, or acute thrombophlebitis), the PE risk increases substantially and warrants immediate anticoagulation. 9, 10
Acute superficial thrombophlebitis involving the proximal greater saphenous vein should be treated with therapeutic anticoagulation for at least 3 months given the 7.5-33% PE risk. 4, 5
Prognostic Factors That Modify Risk
Elevated D-dimer, C-reactive protein, and fibrinogen levels are associated with increased VTE risk and may indicate ongoing thrombotic activity even in the setting of chronic disease. 7
Active malignancy, critical illness, immobility, or thrombophilia substantially increase the risk of recurrent VTE and PE. 7, 1
Prothrombotic fibrin clot phenotype (prolonged clot lysis time) is an emerging risk factor for recurrent DVT and PE. 8
Common Pitfalls
Do not assume that chronic DVT is benign—assess for any acute component or new symptoms that would indicate active thrombosis requiring treatment. 1, 9
Do not dismiss proximal superficial thrombophlebitis as trivial—it carries substantial PE risk and often warrants anticoagulation, not just supportive care. 3, 4, 5
Do not attribute arterial events (stroke, MI) to venous thrombosis unless there is documented right-to-left shunt; investigate arterial risk factors independently. 7
Do not use residual thrombus on ultrasound to guide anticoagulation duration—treatment decisions should be based on provocation status and bleeding risk, not imaging findings. 1